Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:22 PM
Ignite Modification Date:
2025-12-24 @ 2:22 PM
NCT ID:
NCT00062595
Eligibility Criteria:
* Female, 5 years postmenopause.
* Ambulatory.
* Community dwelling.
* Able to ingest calcium and vitamin D supplements.
* Willing to restrict vitamin K intake.
* Stable thyroid dose if appropriate.
* No history of hyperthyroidism, hyperparathyroidism or other metabolic bone diseases.
* Absence of hardware in hip and spine.
* History of malignancy within the last five years.
* Not currently using coumadin or warfarin.
* Vitamin D supplements must be less than 800 IU daily.
* Have not used estrogen or other bone-altering medications (see list in study description) within the last year.
* No history of liver disease or malabsorption.
* No known allergy to vitamin K.
* Have not participated in an investigational drug trial within the last month.
Healthy Volunteers:
True
Sex:
FEMALE
Study:
NCT00062595
Study Brief:
Protocol Section:
NCT00062595